M. Elaine Eyster, MD - Penn State Cancer Institute
Researcher Profile
M. Elaine Eyster, MD
Distinguished Professor, Department of Medicine
Interim Chief, Division of Blood and Vascular Disorders
Interim Chief, Division of Blood and Vascular Disorders
Recent Publications
2023
Martin, KA, Lancki, N, Li, C, Eyster, ME, Sanfilippo, K, Woller, IA, Woller, SC, Kreuziger, LB & Rosovsky, RP 2023, 'Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)', Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, pp. 775. https://doi.org/10.1007/s11239-023-02803-z
Martin, KA, Lancki, N, Kreuziger, LB, Li, C, Eyster, ME, Sanfilippo, K, Woller, SC & Rosovsky, RP 2023, 'DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network', Thrombosis Research, vol. 229, pp. 146-148. https://doi.org/10.1016/j.thromres.2023.07.004
Martin, KA, Lancki, N, Li, C, Eyster, ME, Sanfilippo, K, Woller, IA, Woller, SC, Kreuziger, LB & Rosovsky, RP 2023, 'DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network', Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, pp. 685-690. https://doi.org/10.1007/s11239-023-02774-1
2022
Stine, JG, Schreibman, IR, Faust, AJ, Dahmus, J, Stern, B, Soriano, C, Rivas, G, Hummer, B, Kimball, SR, Geyer, NR, Chinchilli, VM, Loomba, R, Schmitz, K, Sciamanna, C, Strine, C, Wentzel, R, Marlin, S, Sica, C, Vesek, J, Eyster, E, Sinoway, L, Bentz, K, Handley, N, Hershey Fell, B, Mottilla, S, Christ, C, George, S, Novchich, T, Beyer, M, Clarke, K, Myers, T, Glading-Steinruck, M, Krok, K, Ma, T, Riley, T, Thompson, E, Tressler, H, Broach, J, Doan, T, Patrick, S, Reed, S, Hamilton, C, Slavoski, K & Tregea, D 2022, 'NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH', Hepatology, vol. 76, no. 1, pp. 172-185. https://doi.org/10.1002/hep.32274
for the Venous thromboEmbolism Network US (VENUS) VTE Treatment, Anticoagulation Management Group 2022, 'Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment', Research and Practice in Thrombosis and Haemostasis, vol. 6, no. 4, e12740. https://doi.org/10.1002/rth2.12740
Kleiboer, B, Layer, MA, Cafuir, LA, Cuker, A, Escobar, M, Eyster, ME, Kraut, E, Leavitt, AD, Lentz, SR, Quon, D, Ragni, MV, Thornhill, D, Wang, M, Key, NS & Buckner, TW 2022, 'Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study', Journal of Thrombosis and Haemostasis, vol. 20, no. 4, pp. 857-865. https://doi.org/10.1111/jth.15654
2021
George, LA, Monahan, PE, Elaine Eyster, M, Sullivan, SK, Ragni, MV, Croteau, SE, Rasko, JEJ, Recht, M, Samelson-Jones, BJ, MacDougall, A, Jaworski, K, Noble, R, Curran, M, Kuranda, K, Mingozzi, F, Chang, T, Reape, KZ, Anguela, XM & High, KA 2021, 'Multiyear factor VIII expression after AAV gene transfer for hemophilia A', New England Journal of Medicine, vol. 385, no. 21, pp. 1961-1973. https://doi.org/10.1056/NEJMoa2104205
Carrel, L, Arnold-Croop, S, Achtermann, T, Chen, F, Cheng, Y, Liu, D & Eyster, ME 2021, 'Prothrombotic variants as modifiers of clinical phenotype in four related individuals with haemophilia A', Haemophilia, vol. 27, no. 4, pp. e591-e595. https://doi.org/10.1111/hae.14348